7Baggers

Zomedica Corp
(NYSE MKT:ZOM) 

ZOM stock logo

Zomedica Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of...

Founded: 2013
Full Time Employees: 28
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
HealthcarePets
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-03-31 
                              
      net revenue
    		8,799,000 10,471,000 8,095,000 6,964,000 6,500,000 7,895,000 6,997,000 6,131,000 6,262,000 7,337,000 6,347,000 6,020,000 5,482,000 6,157,000 4,776,000 4,246,000 3,751,000 4,080,792 22,514 15,693       
      yoy
    		35.37% 32.63% 15.69% 13.59% 3.80% 7.61% 10.24% 1.84% 14.23% 19.17% 32.89% 41.78% 46.15% 50.88% 21113.47% 26956.65%           
      qoq
    		-15.97% 29.35% 16.24% 7.14% -17.67% 12.83% 14.12% -2.09% -14.65% 15.60% 5.43% 9.81% -10.96% 28.92% 12.48% 13.20% -8.08% 18025.58% 43.47%        
      cost of revenue
    		3,315,000 3,301,000 2,659,000 2,298,000 2,093,000 2,347,000 1,937,000 1,769,000 2,145,000 2,264,000 1,985,000 1,972,000 1,647,000 1,863,000 1,215,000 1,210,000 990,000 1,019,619 17,899 35,876       
      gross profit
    		5,484,000 7,170,000 5,436,000 4,666,000 4,407,000 5,548,000 5,060,000 4,362,000 4,117,000 5,073,000 4,362,000 4,048,000 3,835,000 4,294,000 3,561,000 3,036,000 2,761,000 3,061,173 4,615 -20,183       
      yoy
    		24.44% 29.24% 7.43% 6.97% 7.04% 9.36% 16.00% 7.76% 7.35% 18.14% 22.49% 33.33% 38.90% 40.27% 77061.43% -15142.36%           
      qoq
    		-23.51% 31.90% 16.50% 5.88% -20.57% 9.64% 16.00% 5.95% -18.84% 16.30% 7.76% 5.55% -10.69% 20.58% 17.29% 9.96% -9.81% 66230.94% -122.87%        
      gross margin %
    		62.33% 68.47% 67.15% 67.00% 67.80% 70.27% 72.32% 71.15% 65.75% 69.14% 68.73% 67.24% 69.96% 69.74% 74.56% 71.50% 73.61% 75.01% 20.50% -128.61% NaN% NaN% NaN% NaN% NaN% NaN% 
      expenses
    		                          
      general and administrative
    		5,413,000 6,172,000 5,900,000 6,162,000 6,262,000 6,290,000 6,765,000 7,976,000 8,625,000 9,052,000 6,115,000          1,335,085 988,734 1,248,861 1,557,116 1,404,952 3,231,261 
      research and development
    		1,154,000 1,643,000 1,784,000 1,886,000 1,853,000 2,146,000 1,845,000 1,506,000 1,771,000 3,099,000 867,000 859,000 918,000 777,000 1,131,000 319,000 351,000 664,905 288,453 270,674 2,702,103 3,908,171 630,066 789,946 962,463 7,531,375 
      selling and marketing
    		3,817,000 4,519,000 4,358,000 4,653,000 5,007,000 5,272,000 3,890,000 3,923,000 4,107,000 4,311,000 3,328,000                
      impairment expense
    		    55,833,000   16,024,000                   
      income from operations
    		-4,900,000 -5,164,000 -6,606,000 -8,035,000 -64,548,000 -8,160,000 -7,440,000 -25,067,000 -10,386,000 -11,389,000 -5,948,000 -6,742,000 -7,512,000 -5,136,000 -6,592,000 -5,880,000 -4,314,000 -5,758,860 -6,408,220 -5,328,586 5,000,433 5,302,545 2,333,509 2,857,250 2,844,366 11,691,696 
      yoy
    		-92.41% -36.72% -11.21% -67.95% 521.49% -28.35% 25.08% 271.80% 38.26% 121.75% -9.77% 14.66% 74.13% -10.82% 2.87% 10.35% -186.27% -208.61% -374.62% -286.49% 75.80% -54.65%     
      qoq
    		-5.11% -21.83% -17.78% -87.55% 691.03% 9.68% -70.32% 141.35% -8.81% 91.48% -11.78% -10.25% 46.26% -22.09% 12.11% 36.30% -25.09% -10.13% 20.26% -206.56% -5.70% 127.23% -18.33% 0.45% -75.67%  
      operating margin %
    		-55.69% -49.32% -81.61% -115.38% -993.05% -103.36% -106.33% -408.86% -165.86% -155.23% -93.71% -111.99% -137.03% -83.42% -138.02% -138.48% -115.01% -141.12% -28463.27% -33955.18% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% 
      other income
    		 -48,000 -13,000 -39,000 -44,000 -15,000 -111,000 52,000 84,000 -115,000 2,195,000   1,000 -5,000  1,000    -1,963      
      interest income
    		455,000 515,000 561,000 629,000 730,000 858,000 977,000 1,038,000 1,093,000 1,149,000 1,437,000 1,460,000 1,412,000 1,305,000 1,012,000 -277,000 -107,000 -95,891 -94,302 -112,107 -21,238      
      loss on disposal of assets
    		-15,000 -25,000 -36,000               -21,113 26,760        
      other expense
    		-26,000                          
      foreign exchange income
    		-9,000                          
      income before income taxes
    		-4,495,000 -4,744,000 -6,140,000 -7,386,000 -63,866,000 -7,415,000 -6,724,000 -24,074,000 -9,326,000 -21,947,000 -2,411,000 -5,326,000 -6,177,000 -3,858,000 -5,652,000 -5,655,000 -4,215,000 -3,773,294.5 -6,345,687 -4,710,674 4,979,975 5,307,990 2,450,618 2,857,038 2,845,679 11,676,908 
      income tax expense
    		39,000   12,000    -143,000 -166,000   -77,000 208,000              
      net income
    		-4,534,000 -4,530,000 -6,121,000 -7,398,000 -63,809,000 -7,194,000 -6,697,000 -23,931,000 -9,160,000 -22,406,000 -491,000 -5,249,000 -6,385,000 -2,809,000 -4,995,000 -5,273,000 -3,937,000          
      yoy
    		-92.89% -37.03% -8.60% -69.09% 596.60% -67.89% 1263.95% 355.92% 43.46% 697.65% -90.17% -0.46% 62.18%              
      qoq
    		0.09% -25.99% -17.26% -88.41% 786.98% 7.42% -72.02% 161.26% -59.12% 4463.34% -90.65% -17.79% 127.31% -43.76% -5.27% 33.93%           
      net income margin %
    		-51.53% -43.26% -75.61% -106.23% -981.68% -91.12% -95.71% -390.33% -146.28% -305.38% -7.74% -87.19% -116.47% -45.62% -104.59% -124.19% -104.96% 0% 0% 0% NaN% NaN% NaN% NaN% NaN% NaN% 
      unrealized loss, change in fair value of available-for-sale securities, net of tax
    		-43,000                          
      change in foreign currency translation
    		-14,000 -25,000 -18,000 55,000 62,000 -121,000 139,000 -58,000 -52,000 17,000 -19,000 -47,000 3,000 45,000 -32,000 -40,000 51,000          
      net loss and comprehensive loss
    		-4,591,000 -4,563,000 -6,105,000 -7,353,000 -63,765,000 -7,406,000 -6,333,000 -23,980,000 -9,223,000 -21,973,000 -266,000 -5,304,000 -6,099,000        4,979,975 5,307,990 2,450,618 2,857,038 2,845,679 11,676,908 
      weighted-average number of common shares - basic and diluted
    		979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,949,668,000 979,924,052,000 979,946,407,000 979,899,668,000 979,899,668,000 956,533,761 978,494,076 973,656,518 550,541,878 214,830,818  106,297,975 108,038,398 100,864,022 
      loss per share - basic and diluted
    		  -0.01 -0.01 -0.07 -0.01 -0.01 -0.024 -0.009 -0.023 -0.001 -0.005 -0.007 -0.006 -0.005 -0.005 -0.004  -0.01 -0.005 -0.01   -0.04 -0.03 -0.12 
      foreign exchange gain
    		 4,000 -46,000 58,000 4,000   -46,000    17,000    52,000    -525    7.5 1,313  
      income tax benefit
    		 -214,000 -19,000  -57,000 -221,000 -27,000   459,000 -1,920,000   1,049,000 657,000 -382,000 -278,000          
      unrealized gain, change in fair value of available-for-sale securities, net of tax
    		 -8,000 34,000 -10,000  -91,000 225,000 9,000 -11,000 416,000 244,000 -8,000               
      gain on disposal of assets
    		   1,000 -8,000 -37,000 -134,000 -51,000 12,000 9,000 14,000 1,000               
      unrealized (loss), change in fair value of available-for-sale securities, net of tax
    		    -18,000                      
      interest expense
    		          -64,000 -62,000 -50,000       6,054   651   6,174 
      foreign exchange loss
    		     -47,750 -16,000  -129,000 -13,500 -45,000  -26,000 -29,000 -67,000  7,000 24,570 5,609  2,743 5,692    -1,225 
      selling, general and administrative
    		           9,931,000 10,429,000 8,653,000 9,022,000 8,597,000 6,724,000 8,155,128 6,124,382 5,037,729       
      other loss
    		            -1,000       22,196       
      unrealized gains, change in fair value of available-for-sale securities, net of tax
    		            283,000              
      ​
    		                          
      unrealized losses, change in fair value of available-for-sale securities, net of tax
    		             -66,000 -803,000            
      net income and comprehensive loss
    		             -3,757,500 -5,830,000 -5,313,000 -3,886,000 -3,773,294.5 -6,345,687 -4,710,674       
      other (income) loss
    		               -1,000           
      gain on extinguishment of debt
    		                   -533,414       
      other gains
    		                 -620.25 -600        
      (gain) loss on disposal of assets
    		                   -116       
      expenses:
    		                          
      professional fees
    		                    839,646 282,791 290,682 306,495 279,237 739,394 
      amortization - right-of-use asset
    		                      42,448 127,346 127,345 127,345 
      amortization - intangible assets
    		                    45,399 44,990     
      depreciation
    		                    78,200 77,859 76,416 76,075 70,096 62,054 
      loss on disposal of property and equipment
    		                      69,834    
      loss on right-of-use-asset
    		                          
      gain on settlement of liabilities
    		                       -4,934.25  -19,737 
      amortization - intangible asset
    		                      45,036 272 273  
      loss on right-of-use asset
    		                      59,097    
      weighted-average number of common shares
    		                      118,340,596    
      loss on fixed assets
    		                          
      amortization - intangible
    		                         267 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 
                               
        assets
      		                         
        current assets
      		                         
        cash and cash equivalents
      		9,369,000 9,017,000 7,496,000 8,129,000 8,837,000 7,021,000 9,747,000 7,939,000 10,939,000 12,952,000 21,783,000 27,951,000 8,353,000 27,399,000 45,095,000 186,763,000 192,337,000 194,952,208 271,411,043 276,209,816 52,032,640 29,103,049 1,496,752 510,586 2,487,651 
        available-for-sale securities
      		38,138,000 44,239,000 45,628,000 49,938,000 54,770,000 64,332,000 67,128,000 71,569,000 72,023,000 77,545,000 84,424,000 102,522,000 112,698,000 87,693,000 74,200,000           
        trade receivables
      		4,428,000 3,012,000 3,144,000 2,297,000 1,569,000 2,423,000 1,759,000 1,383,000 1,649,000 1,197,000 1,348,000 654,000 428,000 596,000 719,000 414,000 341,000 315,418 6,938 4,264      
        inventory
      		5,875,000 5,545,000 5,522,000 5,672,000 5,358,000 5,058,000 5,429,000 5,507,000 5,062,000 5,123,000 3,737,000 3,634,000 2,743,000 2,746,000 2,400,000 4,819,000 3,606,000 2,847,985 1,423,923 793,898      
        prepaid expenses and deposits
      		1,846,000 1,787,000 2,417,000 1,945,000 2,135,000 2,291,000 2,579,000 2,100,000 1,616,000 2,064,000 3,018,000 3,562,000 4,856,000 3,799,000 3,611,000 2,315,000 1,696,000 1,841,814 1,633,846 222,478 932,408 782,647 520,290  1,497,425 
        other receivables
      		373,000 443,000 486,000 622,000 555,000 648,000 628,000 724,000 780,000 1,001,000 1,084,000 1,302,000 1,085,000 1,268,000 1,078,000 315,000 470,000 450,081 258,359 268,501      
        total current assets
      		60,029,000 64,043,000 64,693,000 68,603,000 73,224,000 81,773,000 87,270,000 89,222,000 92,069,000 99,882,000 115,394,000 139,625,000 130,163,000 123,501,000 127,103,000 194,626,000 198,450,000 200,407,506 274,734,109 277,498,957      
        property and equipment
      		20,459,000 20,912,000 21,381,000 21,855,000 22,238,000 24,589,000 25,540,000 24,979,000 23,971,000 10,347,000 8,259,000 7,291,000 6,799,000 6,809,000 6,727,000 1,710,000 1,373,000 1,205,546 706,266 265,845 720,701 798,901 876,760 729,142 805,218 
        right-of-use assets
      		1,863,000 2,023,000 2,181,000 2,336,000 2,488,000 1,611,000                    
        intangible assets
      		37,975,000 38,808,000 40,101,000 41,395,000 42,769,000 52,538,000 51,616,000 53,218,000 54,802,000 55,364,000 56,928,000 48,071,000 48,433,000 41,799,000 42,778,000 32,097,000 32,439,000 33,519,560 473,966 373,851 408,583 453,370 498,359 543,395 513,735 
        other assets
      		1,076,000 1,101,000 1,149,000 1,115,000 1,123,000 1,100,000 1,143,000 1,185,000 819,000 822,000 852,000 265,000 265,000 265,000 265,000 265,000 265,000 265,000        
        total assets
      		121,533,000 127,039,000 130,905,000 136,472,000 142,993,000 207,360,000 214,115,000 219,881,000 243,701,000 253,197,000 275,052,000 274,778,000 279,598,000 279,610,000 282,299,000 275,478,000 277,990,000 280,399,293 277,502,151 280,352,284      
        liabilities and shareholders’ equity
      		                         
        current liabilities
      		                         
        accounts payable
      		2,200,000 1,718,000 1,645,000 2,073,000 2,295,000 1,929,000 2,376,000 2,323,000                  
        accrued income taxes
      		190,000 252,000 51,000 109,000 143,000 117,000 96,000 131,000 66,000 65,000 114,000 74,000 233,000 187,000 41,000 41,000 217,000 239,924        
        current portion of lease obligations
      		715,000 717,000 705,000 687,000 670,000 523,000 632,000 740,000 847,000 916,000 679,000 641,000 641,000 641,000 578,000 523,000 422,000 414,695 407,278 302,112 242,491 232,496 222,795   
        customer contract liabilities
      		352,000 368,000 353,000 330,000 319,000 331,000 293,000 271,000 260,000 276,000 257,000 255,000 242,000 207,000 205,000 153,000 148,000 198,112        
        accrued expenses and other current liabilities
      		5,101,000 6,394,000 5,678,000 4,928,000 3,978,000 6,431,000 4,667,000 4,370,000                  
        total current liabilities
      		8,558,000 9,449,000 8,432,000 8,127,000 7,405,000 9,331,000 8,064,000 7,835,000 8,008,000 9,032,000 6,740,000 7,210,000 8,597,000 7,811,000 7,126,000 4,474,000 4,118,000 4,339,700 4,872,152 3,397,315      
        lease obligations
      		1,296,000 1,467,000 1,648,000 1,831,000 2,010,000 1,291,000 1,445,000 1,552,000 1,657,000 1,814,000 1,073,000 781,000 941,000 1,097,000 1,058,000 1,184,000 855,000 964,191 1,069,687 886,956 1,154,304 1,218,661 1,281,124   
        deferred tax liabilities
      		45,000 27,000 435,000 435,000 435,000 456,000 694,000 759,000 955,000 1,138,000 998,000 1,245,000 1,245,000 1,245,000 2,249,000 3,048,000 3,430,000 3,709,312        
        other liabilities
      		416,000 467,000 466,000 455,000 448,000 399,000 808,000 736,000 907,000 944,000 1,433,000 2,181,000 1,965,000 1,883,000 2,872,000 391,000 391,000 360,797        
        total liabilities
      		10,588,000 11,642,000 11,217,000 11,115,000 10,549,000 11,696,000 11,271,000 11,164,000 11,806,000 13,180,000 14,168,000 15,299,000 16,540,000 12,218,000 13,518,000 9,258,000 8,949,000 9,513,950 5,941,839 4,284,271      
        commitments and contingencies
      		                         
        shareholders’ equity
      		                         
        unlimited common shares, no par value; 979,949,668 issued and outstanding at march 31, 2026 and december 31, 2025
      		380,973,000                         
        additional paid-in capital
      		34,176,000 34,037,000 33,765,000 33,329,000 33,063,000 32,518,000 32,292,000 31,832,000 31,030,000 29,929,000 28,824,000 27,156,000 25,431,000 23,666,000 22,227,000 13,846,000 11,354,000 9,313,136 6,732,887 5,601,641 18,256,678 8,639,590 4,500,263 3,625,083 3,625,083 
        accumulated deficit
      		-304,307,000 -299,773,000 -295,243,000 -289,122,000 -281,724,000 -217,915,000 -210,721,000 -204,024,000 -180,093,000 -170,933,000 -148,526,000 -148,038,000 -142,789,000 -136,404,000 -133,597,000 -128,601,000 -123,328,000 -119,391,398 -116,101,406 -109,755,719 -64,796,423    -49,200,803 
        accumulated comprehensive income
      		103,000 160,000 193,000 177,000 132,000 88,000 300,000 -64,000 -15,000 48,000    -843,000  13,000 53,000         
        total shareholders' equity
      		110,945,000 115,397,000 119,688,000 125,357,000 132,444,000 195,664,000 202,844,000 208,717,000 231,895,000 240,017,000 260,884,000 259,479,000 263,058,000 267,392,000 268,781,000 266,220,000 269,041,000 270,885,343 271,560,312 276,068,013      
        total liabilities and shareholders’ equity
      		121,533,000 127,039,000 130,905,000 136,472,000 142,993,000 207,360,000 214,115,000 219,881,000 243,701,000 253,197,000 275,052,000 274,778,000 279,598,000 279,610,000 282,299,000 275,478,000 277,990,000         
        goodwill
      		     45,556,000 45,556,000 45,556,000 61,580,000 61,580,000 73,774,000 63,979,000 63,979,000 63,979,000 64,230,000 43,288,000 43,288,000 43,287,765        
        unlimited common shares, no par value; 979,949,668 issued and outstanding at december 31, 2025 and december 31, 2024
      		 380,973,000                        
        noncurrent available-for-sale securities
      		  1,242,000 1,001,000 966,000                     
        unlimited common shares, no par value; 979,949,668 issued and outstanding at september 30, 2025 and december 31, 2024
      		  380,973,000                       
        unlimited common shares, no par value; 979,949,668 issued and outstanding at june 30, 2025 and december 31, 2024
      		   380,973,000                      
        unlimited common shares, no par value; 979,949,668 issued and outstanding at march 31, 2025 and december 31, 2024
      		    380,973,000                     
        unlimited common shares, no par value; 979,949,668 issued and outstanding at december 31, 2024 and december 31, 2023
      		     380,973,000                    
        right-of-use asset
      		      1,828,000 2,042,000 2,253,000 2,466,000 1,681,000 1,355,000 1,511,000 1,665,000 1,567,000 1,638,000 1,218,000 1,319,810 1,419,790 1,132,548 1,380,744 1,441,124 1,499,906 1,103,658 1,231,003 
        non current available-for-sale securities
      		      966,000 3,482,000 7,964,000 10,005,000 11,787,000 11,920,000 26,409,000 40,712,000 39,197,000           
        unlimited common shares, no par value; 979,949,668 issued and outstanding at september 30, 2024 and december 31, 2023
      		      380,973,000                   
        unlimited common shares, no par value; 979,949,668 issued and outstanding at june 30, 2024 and december 31, 2023
      		       380,973,000                  
        accounts payable and accrued liabilities
      		        6,676,000 7,668,000 5,598,000 6,144,000 7,419,000 6,698,000 6,244,000 3,491,000 3,109,000 3,225,348 4,464,874 3,095,203 1,827,761 1,731,469 1,578,968 2,087,525 1,577,525 
        other current liabilities
      		        159,000 107,000 92,000 96,000 62,000 78,000 58,000 266,000 222,000 261,621        
        unlimited common shares, no par value; 979,949,668 issued and outstanding at march 31, 2024 and december 31, 2023
      		        380,973,000                 
        construction in progress
      		         12,481,000 6,279,000 2,146,000 1,886,000 692,000 202,000           
        unlimited common shares, no par value; 979,949,668 issued and outstanding at december 31, 2023 and december 31, 2022
      		         380,973,000                
        liability due to qorvo
      		          3,654,000 3,591,000 3,529,000             
        unlimited common shares, no par value; 979,949,668 issued and outstanding at september 30, 2023 and december 31, 2022
      		          380,973,000               
        accumulated comprehensive loss
      		          -387,000 -612,000 -557,000             
        unlimited common shares, no par value; 979,949,668 issued and outstanding at june 30, 2023 and december 31, 2022
      		           380,973,000              
        unlimited common shares, no par value; 979,949,668 issued and outstanding at march 31, 2023 and december 31, 2022
      		            380,973,000             
        unlimited common shares, no par value; 979,949,668 and 979,899,668 issued and outstanding at december 31, 2022 and december 31, 2021
      		             380,973,000            
        unlimited common shares, no par value; 979,949,668 and 979,899,668 issued and outstanding at september 30, 2022 and december 31, 2021
      		              380,973,000           
        accumulated comprehensive
      		              -822,000           
        ​
      		                         
        assets in process
      		                547,000         
        debt security
      		               1,000,000          
        unlimited common shares, no par value; 979,899,668 issued and outstanding at june 30, 2022 and december 31, 2021
      		               380,962,000          
        unlimited common shares, no par value; 979,899,668 issued and outstanding at march 31, 2022 and december 31, 2021
      		                380,962,000         
        current assets:
      		                         
        liabilities, mezzanine and shareholders' equity
      		                         
        current liabilities:
      		                         
        current portion of debt obligation
      		                         
        mezzanine equity:
      		                         
        series 1 preferred shares, without par value; 20 shares authorized 0 and 12 series 1 issued and outstanding at december 31, 2021 and december 31, 2020, respectively
      		                         
        shareholders' equity:
      		                         
        unlimited common shares without par value; 979,899,668 and 642,036,228 issued and outstanding at december 31, 2021 and december 31, 2020, respectively
      		                 380,961,940        
        common stock subscribed
      		                         
        accumulated other comprehensive income
      		                 1,665        
        total liabilities and equity
      		                 280,399,293        
        current portion of debt obligations
      		                         
        series 1 preferred shares, no par value;
      		                         
        20 shares authorized
      		                         
        0 and 12 series 1 preferred shares issued and outstanding
      		                         
        at september 30, 2021 and december 31, 2020, respectively
      		                         
        shareholders' equity
      		                         
        unlimited common shares, no par value;
      		                         
        979,738,168 and 642,036,228 issued and outstanding
      		                  380,928,831       
        common shares subscribed
      		                         
        total liabilities, mezzanine equity and shareholders' equity
      		                  277,502,151 280,352,284      
        series 1 preferred shares, no par value; 20 shares authorized 0 and 12 series 1 preferred shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively
      		                         
        unlimited common shares, no par value; 977,950,993 and 642,036,228 issued and outstanding at june 30, 2021 and december 31, 2020, respectively
      		                   380,222,091      
        tax credits
      		                    129,269     
        current assets: - sum
      		                    53,094,317 30,068,192  1,806,789 4,061,068 
        liabilitites and shareholders' equity
      		                         
        current liabilities: - sum
      		                    2,070,252 1,963,965  2,087,525 1,577,525 
        capital stock
      		                         
        series 1 preferred shares, without par value; 20 shares authorized
      		                    11,961,397  11,961,397 11,961,397 11,961,397 
        unlimited common shares without par value; issued and outstanding 564,051,438 common shares
      		                    87,958,137     
        capital stock - sum
      		                    53,379,789    5,033,499 
        tax credits and other receivables
      		                     182,496    
        liabilities and shareholders' equity
      		                         
        series 1 preferred shares, without par value;
      		                         
        issued and outstanding
      		                         
        12 series 1 preferred shares
      		                     11,961,397    
        unlimited common shares without par value;
      		                         
        361,039,946 common shares
      		                     67,328,922    
        shares to be issued
      		                     1,465,500    
        tax credits and other receivable
      		                      142,463   
        current assets - sum
      		                      2,159,505   
        current liabilities - sum
      		                      1,801,763   
        unlimited common shares without par value; issued and outstanding 128,871,732 common shares
      		                      39,998,442   
        prepaid expenses, deposits and deferred financing costs
      		                       1,228,585  
        tax credits receivable
      		                       67,618  
        unlimited common shares without par value; issued and outstanding 108,038,398 common shares
      		                       38,566,820 38,647,822 
        trade and other receivable
      		                        75,992 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-12-31 2024-12-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-03-31 
                         
          cash flows from operating activities:
        		                 
          net loss
        		-4,530,000 -7,194,000 -22,406,000    -2,809,000   -3,937,000 -3,289,992 -6,345,687     -11,676,908 
          adjustments for:
        		                 
          depreciation
        		519,000 443,000 292,000   164,000 156,000 109,000 79,000 82,000 90,328 60,444 341 1,443 76,416 207,054 62,054 
          amortization - intangible assets
        		1,397,000 1,607,000 1,578,000   1,199,000 1,076,000 1,045,000 758,000 737,000 737,893 46,732 409 -46 45,036 809 267 
          impairment loss
        		0 0                
          loss on disposal of property and equipment
        		25,000  -9,000    -2,000 0   841 4,806   69,834   
          stock-based compensation
        		727,000 345,000 1,105,000   1,765,000 1,439,000 1,919,000 2,492,000 2,041,000 2,589,434 1,437,779 52,125 -19,178 155,022 2,341,104 2,341,104 
          noncash portion of rent benefit
        		-11,000                 
          accretion/amortization of available-for-sale securities
        		-105,000 -383,000 -493,000   -654,000 -500,000           
          equity in loss of nonconsolidated entities
        		48,000                 
          deferred tax expense
        		-269,000 -238,000                
          change in assets and liabilities, net of acquisitions:
        		                 
          purchased inventory
        		3,000 455,000 291,000   -731,000 -371,000 -1,065,000 -1,567,000 -1,005,000  -1,081,525      
          prepaid expenses and deposits
        		635,000 282,000 883,000   -1,022,000 -135,000 -920,000 -538,000 128,000 -68,745 -498,306      
          trade receivables
        		131,000 -665,000 120,000   144,000 159,000 -346,000 -69,000 -27,000        
          other receivables
        		133,000 33,000 155,000   263,000 -403,000 -62,000 156,000 -25,000 -41,721 10,142      
          accounts payable
        		55,000 -508,000                
          accrued income tax
        		63,000 22,000 -52,000   46,000 146,000 0 -176,000 -23,000        
          accrued expenses and other current liabilities
        		268,000 1,654,000                
          customer contract liabilities
        		11,000 -3,000 3,000   116,000 -30,000 106,000 10,000 -35,000        
          other liabilities
        		1,000 -409,000 -490,000   134,000 -533,000 -22,000 0 30,000        
          net cash from operating activities
        		-899,000 -4,525,000 -5,015,000   -4,257,000 -2,383,000 -2,770,000 -4,046,000 -2,471,000 -4,901,352 -4,997,962      
          capital expenditures
        		0 0 0   0 0 0 0 0 0 0      
          free cash flows
        		-899,000 -4,525,000 -5,015,000   -4,257,000 -2,383,000 -2,770,000 -4,046,000 -2,471,000 -4,901,352 -4,997,962      
          cash flows from investing activities:
        		                 
          securities matured
        		2,636,000 3,993,000                
          investment in nonconsolidated entities
        		 0                
          investment in property and equipment
        		-107,000 -575,000 -115,000   -113,000 -204,000 -432,000 -68,000 -83,000 -50,163 -54,321     -69,087 
          acquisition of intangibles
        		-80,000 -1,502,000 -30,000   -4,000,000 -96,000           
          net cash from investing activities
        		2,449,000 1,916,000 -3,829,000   -14,792,000 -15,351,000 -138,886,000 -1,437,000 -206,000 -71,583,069 -201,021      
          cash flows from financing activities:
        		                 
          stock issuance costs paid
        		 0                
          net cash from financing activities
        		 0     0    23,923 400,210      
          increase in cash and cash equivalents
        		1,550,000     -19,049,000 -17,734,000 -141,648,000 -5,483,000 -2,677,000 -76,460,498 -4,798,773 -4,676,706 26,620,131 986,166   
          effect of exchange rate changes on cash
        		-29,000 -117,000 13,000    38,000   62,000        
          cash and cash equivalents, beginning of year
        		0 0 0   27,399,000 0 0 0 194,952,000        
          cash and cash equivalents, end of period
        		1,521,000 -2,726,000 -8,831,000 -6,168,000 19,598,000 8,353,000     -76,458,835 -4,798,773 22,929,591 27,606,297 1,496,752  2,296,731 
          noncash activities:
        		                 
          change in fair value of available-for-sale securities, net of tax
        		-8,000 -91,000 416,000   283,000 -66,000           
          property and equipment accrued for in accounts payable
        		 69,000                
          transfer of property and equipment into intangibles
        		0 1,027,000                
          transfer of inventory into property and equipment
        		-28,000 -89,000 114,000   738,000 40,000 3,734,000 311,000 246,000 346,500       
          intangible assets accrued for in accounts payable
        		24,000                 
          right-of-use assets obtained in exchange for operating lease obligations
        		0                 
          supplemental cash flow information:
        		                 
          interest received on available-for-sale securities
        		519,000 529,000                
          gain on disposal of property and equipment
        		                 
          loss on conversion of notes receivable
        		                 
          equity in earnings of nonconsolidated entities
        		 43,000                
          deferred tax liabilities
        		      -1,037,000 -658,000 -382,000 -279,000        
          investment in debt security
        		  0   -1,750,000 0 0          
          investment in acquisitions, net of cash acquired
        		  -11,299,000               
          decrease in cash and cash equivalents
        		 -2,609,000 -8,844,000              356,466 
          gain on conversion of notes receivable
        		  0               
          non cash portion of rent benefit
        		  189,000               
          accounts payable and accrued liabilities
        		  1,469,000   721,000 434,000 2,728,000 410,000 -118,000 -1,804,208 1,369,671     5,397,418 
          deferred tax benefits
        		                 
          other current liabilities
        		  16,000   -16,000 20,000 -208,000 44,000 -40,000        
          proceeds on sale of (investment in) available-for-sale securities
        		                 
          investment in construction in progress
        		  -1,920,000    -490,000           
          cash received from warrant exercises
        		      0    23,473 1 -8,962,809     
          transfer of construction in progress into property and equipment and intangibles
        		  655,000   401,000 -464,000           
          investment in available-for-sale securities
        		     -8,072,000            
          interest received
        		     783,000 1,182,000 790,000 -294,000 -90,000 -730,572 340,448      
          cash from operating activities
        		                 
          cash from investing activities
        		                 
          cash and cash equivalents, beginning of period
        		          0 0 27,606,297 986,166 510,586  1,940,265 
          ●
        		                 
          net income
        		     -6,385,000            
          non cash portion of rent expense
        		     -1,000 7,000 0          
          ​
        		                 
          capital
        		     217,000            
          consumables
        		                 
          other
        		                 
          total revenue
        		     399,000            
          gain on other assets
        		                 
          gain on extinguishment of debt
        		          0 0      
          cash proceeds from issuance of common shares and warrants
        		                 
          cash paid for shares and warrant issuance costs
        		                 
          cash received from stock option exercises
        		          451 400,208     600,000 
          cash and cash equivalents, end of year
        		      -17,696,000 -141,668,000 -5,574,000 192,337,000        
          deferred financing fees charged to stock issuance costs
        		                 
          net equity effect of preferred share exchange
        		          0       
          adjustments for
        		                 
          loss on other assets
        		          -6,054 0      
          loss on right-of-use assets
        		                 
          change in non-cash operating working capital, net of acquisitions
        		                 
          investment in securities
        		                 
          investment in assets purchased
        		                 
          accounts receivable recorded in intercompany account
        		                 
          (gain) loss on right-of-use assets
        		                 
          change in non-cash operating working capital
        		                 
          investment in intangibles
        		          -133,487 -146,850      
          investment in assets in process
        		         -123,000        
          noncash investing and financing activities
        		                 
          loss on sale of property and equipment
        		                 
          non-cash portion of rent expense
        		          1,900 656 0 2,007 4,012   
          change in non-cash operating working capital, net of acquisition
        		                 
          inventory
        		                 
          cash from sale of property and equipment
        		          0 150   5,400   
          cash from lease cancellation or modification
        		                 
          investment in subsidiary acquisition, net of cash acquired
        		                 
          proceeds from issuance of common shares, warrants and pre-funded warrants
        		          0 0 5,998,717     
          cash received from shares to be issued
        		                 
          cash paid on stock issuance costs
        		          -1 1      
          deferred financing fees charge to stock issuance costs
        		                 
          interest paid
        		              651 6,174 6,174 
          trade receivable
        		           -2,674      
          cash received for government loan
        		                 
          account receivable recorded in intercompany account
        		                 
          net loss for the period
        		                 
          amortization - right-of-use-asset
        		                 
          loss on right-of-use asset
        		              59,097   
          stock issued for services
        		                792,104 
          tax credits and other receivables
        		                 
          prepaid expenses
        		            -299,745 44,659 11,625 362,268 170,591 
          deposits
        		              397,403 71,507 364,063 
          proceeds from financing of preferred shares
        		                 
          cash flows from financing activities: - sum
        		                3,006,828 
          cash flows (used in) from investing activities:
        		                 
          cash from lease repurchase
        		              1,002,113   
          cash flows (used in) from investing activities: - sum
        		                 
          amortization - right-of-use asset
        		              42,448  127,345 
          tax and other receivable
        		                 
          proceeds from issuance of shares and warrants
        		              2,500,000   
          proceeds from stock option exercises
        		                 
          stock issuance costs
        		                -593,172 
          cash flows from (used) in investing activities:
        		                 
          cash flows from (used) in investing activities: - sum
        		              1,007,513   
          supplemental cash flows information:
        		                 
          loss on fixed asets
        		                 
          trade and other receivable
        		                -24,313 
          cash proceeds from issuance of preferred shares
        		                 
          cash proceeds from issuance of common shares
        		                 
          cash received from sale of fixed assets
        		                 
          loss on fixed assets
        		                 
          cash flows (used) from financing activities:
        		                 
          cash proceeds from financing of preferred shares
        		                 
          cash proceeds from financing of common shares
        		                 
          cash flows (used) from financing activities: - sum
        		                 
          cash received from financing
        		                3,000,000 
          cash flows from investing activities: - sum
        		                -69,087